Recombinant Human BTNL9 (C-Fc)

Description

EnkiLife provides the Recombinant Human BTNL9 (C-Fc) protein,aslo know as Butyrophilin-like protein 9,BTNL9, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Butyrophilin-like Protein 9 is produced by our Mammalian expression system and the target gene encoding Ser35–Lys256 is expressed with a human IgG1 Fc tag at the C-terminus.Accession:Q6UXG8. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:52 KDa. Background:Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.